Evidence map›Paper›PMID 34206828›Full record

ArticleTropical medicine and infectious disease2021

Performance of MALDI-TOF Mass Spectrometry in the Philippines.

Morichika Osa, Maria Cecilia Belo, Zita Dela Merced, Annavi Marie G Villanueva, Jaira Mauhay, Alyannah Celis, Melissa Catli, Shuichi Suzuki, Tatsuya Ukawa, Shingo Tamaki and 7 more

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Infection Prevention and Control: Practical and Educational Advances.Tropical medicine and infectious disease · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Morichika OsaSchool of Tropical Medicine and Global Health, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8102, Japan.
Maria Cecilia BeloSan Lazaro Hospital, Quiricada St., Sta. Cruz, Manila 1003, Metro Manila, Philippines.
Zita Dela MercedSan Lazaro Hospital, Quiricada St., Sta. Cruz, Manila 1003, Metro Manila, Philippines.
Annavi Marie G VillanuevaSchool of Tropical Medicine and Global Health, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8102, Japan.ORCID 0000-0001-7478-9903
Jaira MauhaySan Lazaro Hospital-Nagasaki University Collaborative Research Office, San Lazaro Hospital, Quiricada St., Sta. Cruz, Manila 1003, Philippines.
Alyannah CelisSan Lazaro Hospital-Nagasaki University Collaborative Research Office, San Lazaro Hospital, Quiricada St., Sta. Cruz, Manila 1003, Philippines.
Melissa CatliSan Lazaro Hospital-Nagasaki University Collaborative Research Office, San Lazaro Hospital, Quiricada St., Sta. Cruz, Manila 1003, Philippines.
Shuichi SuzukiSchool of Tropical Medicine and Global Health, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8102, Japan.ORCID 0000-0001-8922-7428
Tatsuya UkawaSchool of Tropical Medicine and Global Health, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8102, Japan.
Shingo TamakiInstitute of Tropical Medicine, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8523, Nagasaki, Japan.
Bhim Gopal DhoubhadelSchool of Tropical Medicine and Global Health, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8102, Japan.
Koya AriyoshiInstitute of Tropical Medicine, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8523, Nagasaki, Japan.
Elizabeth Freda O TelanSan Lazaro Hospital, Quiricada St., Sta. Cruz, Manila 1003, Metro Manila, Philippines.
Dorcas Valencia UmipigSan Lazaro Hospital, Quiricada St., Sta. Cruz, Manila 1003, Metro Manila, Philippines.
Christopher M ParrySchool of Tropical Medicine and Global Health, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8102, Japan.ORCID 0000-0001-7563-7282
Nobu SaitoSchool of Tropical Medicine and Global Health, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8102, Japan.ORCID 0000-0002-4396-5000
Chris SmithSchool of Tropical Medicine and Global Health, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8102, Japan.ORCID 0000-0001-9238-3202
Nagasaki University · JPLiverpool School of Tropical Medicine · GBOita University · JPUniversity of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of the causative pathogen in infectious diseases is important for surveillance and to guide treatment. In low- and middle-income countries (LMIC), conventional culture and identification methods, including biochemical methods, are reference-standard. Biochemical methods can lack sensitivity and specificity and have slow turnaround times, causing delays in definitive therapy. Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) is a rapid and accurate diagnostic method. Most studies comparing MALDI-TOF MS and biochemical methods are from high-income countries, with few reports from LMIC with tropical climates. The aim of this study was to assess the performance of MALDI-TOF MS compared to conventional methods in the Philippines. Clinical bacterial or fungal isolates were identified by both MALDI-TOF MS and automated (VITEK2) or manual biochemical methods in the San Lazaro Hospital, Metro Manila, the Philippines. The concordance between MALDI-TOF MS and automated (VITEK2) or manual biochemical methods was analyzed at the species and genus levels. In total, 3530 bacterial or fungal isolates were analyzed. The concordance rate between MALDI-TOF MS and biochemical methods was 96.2% at the species level and 99.9% at the genus level. Twenty-three isolates could not be identified by MALDI-TOF MS. In this setting, MALDI-TOF MS was accurate compared with biochemical methods, at both the genus and the species level. Additionally, MALDI-TOF MS improved the turnaround time for results. These advantages could lead to improved infection management and infection control in low- and middle-income countries, even though the initial cost is high.

Indexed as

bacterial infectionbiochemical methodsLMICMALDI–TOF MSPhilippinesVITEK2

Identifiers

PMID34206828
PMCPMC8293455
OpenAlexW3174176955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.